News

Kinetic Physical Therapy and Wellness here in Greenville is helping veterans out. The local business hosted a Veteran’s ...
A Russia native has brought her education back to her hometown to help people of all ages with physical therapy and wellness.
Vertex Pharmaceuticals' (NASDAQ: VRTX) remarkable momentum came to a screeching halt this week. The big biotech stock had ...
EPS and sales below estimates but raised its 2025 revenue outlook, driven by CF drug demand and new product launches in the U ...
A new treatment is available at WVU Medicine Princeton Community Hospital for people dealing with arthritis pain. According ...
Leading the way with our groundbreaking research and innovative teaching spanning chemistry, physics and astronomy, and mathematics and statistics. Our students go on to make an impact across a huge ...
PSP said in a Facebook post on Wednesday evening that this would be the party's "first ever" physical rally. In addition to residents of Marymount SMC, PSP also invited those from Kebun Baru SMC ...
With a market cap of $122.6 billion, Vertex Pharmaceuticals Incorporated (VRTX) operates as a global biotechnology company that develops and commercializes therapies for treating cystic fibrosis (CF).
For many, that might not be a bad idea. Studies show that patients who receive physical therapy at home do as well as those who go to an in-patient facility. What exercises you do and how long you ...
Regulatory submissions are expected in 2026, and if approved, would be the second cell therapy for type 1 diabetes. Vertex Pharmaceuticals is conducting the pivotal phase 3 portion of a phase 1/2/3 ...
ToolGen's CEO Jong Sang Ryu commented, "Vertex's CASGEVY was born from ToolGen's proprietary CRISPR RNP technology. As the company behind the world's first CRISPR Cas9-based gene therapy, we believe ...